NEW YORK, Dec. 12, 2019 /PRNewswire/ -- WeissLaw
LLP is investigating possible breaches of fiduciary duty and
other violations of law by the Board of Directors of Synthorx, Inc.
("Synthorx" or the "Company") (NASDAQ: THOR) in connection with the
proposed acquisition of the Company by Sanofi SA (NASDAQ:
SNY). Under the terms of the acquisition agreement, THOR
shareholders will receive $68 per
share in cash. The deal is scheduled to close in the first
quarter of 2020.
If you own THOR shares and wish to discuss
this investigation or have any questions concerning this notice or
your rights or interests, visit our website:
https://weisslawllp.com/synthorx-inc-investigation/
Or please contact:
Joshua Rubin, Esq.
WeissLaw LLP
1500 Broadway, 16th Floor
New York, NY 10036
(212) 682-3025
(888) 593-4771
stockinfo@weisslawllp.com
WeissLaw is investigating whether the Synthorx Board acted to
maximize shareholder value prior to entering into the acquisition
agreement. Notably, Sanofi will have access to the Company's
first-of-its-kind Expanded Genetic Alphabet platform for the
treatment of autoimmune disorder. Additionally, the FDA
recently cleared the Company's investigational new drug application
for THOR-707 in solid tumors.
Given these facts, WeissLaw is concerned whether the proposed
acquisition agreement undervalues the Company, whether the Board
ran a fair process, and whether all material information related to
the proposed acquisition is fully and fairly disclosed.
WeissLaw LLP has litigated hundreds of stockholder class and
derivative actions for violations of corporate and fiduciary
duties. We have recovered over a billion dollars for
defrauded clients and obtained important corporate governance
relief in many of these cases. If you have information or
would like legal advice concerning possible corporate wrongdoing
(including insider trading, waste of corporate assets, accounting
fraud, or materially misleading information), consumer fraud
(including false advertising, defective products, or other
deceptive business practices), or anti-trust violations, please
email us at stockinfo@weisslawllp.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/shareholder-alert-weisslaw-llp-investigates-synthorx-inc-300974233.html
SOURCE WeissLaw LLP
